Azeem Latib

Azeem Latib

Section Head of Interventional Cardiology

MD

Montefiore Medical Center, New York City, US

  • LinkedIn
  • X
  • Radcliffe
  • OrcidID

Research areas

Biography

Dr Mohamed Azeem Latib was born and raised in South Africa, where he also completed his early medical training. He later advanced his clinical and professional career internationally. He now resides in New York City, where he serves as the Section Head and Director of Interventional Cardiology and the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart & Vascular Care. His career has spanned multiple countries and premier cardiovascular institutions.

 

Academic History

Dr Latib earned his Bachelor of Medicine, Bachelor of Surgery (MB BCh) from the University of the Witwatersrand in Johannesburg, South Africa, in 1995. He completed a fellowship with the College of Physicians of South Africa in 2002 and received his certificate in cardiology in 2005.

He pursued advanced subspecialty training in Europe, completing a Master’s degree in Interventional Cardiology at the San Raffaele Scientific Institute and University Vita-Salute in Milan, Italy, in 2008. In 2018, he expanded his expertise further with a certificate of advanced studies in aortic structural interventions from the University of Zurich.

 

Career Overview

Dr Latib is internationally recognized as a leading interventional cardiologist specializing in complex coronary interventions and structural heart disease. His clinical expertise includes transcatheter aortic valve replacement (TAVR), MitraClip procedures, and innovative minimally invasive therapies for mitral and tricuspid valve disease.

He is actively involved in advancing new technologies and is currently contributing to the development of the NeoChord NeXuS Transcatheter Mitral Chordal Repair Device and procedure.

Dr Latib has published more than 550 peer-reviewed journal articles. He serves on the editorial boards of multiple leading cardiology journals, including Cardiac Interventions Today, the Journal of the American College of Cardiology, Cardiovascular Interventions, and Cardiovascular Revascularization Medicine. He is also a reviewer for numerous journals and a regular faculty member at major international conferences.

He is an active member of several professional societies, including the American College of Cardiology and the European Society of Cardiology.

 

Career Timeline

  • 1995: MB BCh, University of the Witwatersrand
  • 2002: Fellowship, College of Physicians of South Africa
  • 2005: Certificate in Cardiology, College of Physicians of South Africa
  • 2008: Master’s in Interventional Cardiology, San Raffaele Scientific Institute & University Vita-Salute
  • 2018: Certificate of Advanced Studies in Aortic Structural Interventions, University of Zurich
  • Current: Section Head and Director of Interventional Cardiology & Director of Structural Heart Interventions at Montefiore-Einstein Center for Heart & Vascular Care

 

Recognition

Dr Latib is widely acknowledged for his contributions to structural heart interventions and coronary therapeutics. He is frequently invited to speak at international cardiovascular conferences and is recognized for his pioneering work in device innovation and minimally invasive valve therapies. His extensive academic contributions and leadership roles within major cardiology journals further highlight his influence in the field.

 

Areas of Speciality

  • Complex Coronary Interventions
  • Transcatheter Aortic Valve Replacement (TAVR)
  • Transcatheter Mitral and Tricuspid Valve Interventions
  • Structural Heart Disease
  • New Device Innovation

 

Sources

Media

Broadcast

Transcatheter Interventions Online 2025 - Day Four

Ajay J Kirtane, Azeem Latib, Eric Secemsky, et al

Broadcast

Transcatheter Interventions Online 2025 - Day Two

Nicolas M Van Mieghem, David Hildick-Smith, Roxana Mehran, et al

Broadcast

Transcatheter Interventions Online 2025 - Day One

Nicolas M Van Mieghem, David Hildick-Smith, Roxana Mehran, et al

Broadcast

Transcatheter Interventions Online 2023 - Day Three

Nicolas M Van Mieghem, Roxana Mehran, Holger Thiele, et al

Watch time: 4h

Broadcast

Transcatheter Interventions Online 2023 - Day Two

David Hildick-Smith, Ajay J Kirtane, Nicolas M Van Mieghem, et al

Watch time: 4h

Broadcast

Transcatheter Interventions Online 2023 - Day One

Nicolas M Van Mieghem, Azeem Latib, Kendra J Grubb, et al

Watch time: 4h

Broadcast

JIM 2021: Live Cases from Rotterdam

Nicolas M Van Mieghem, Roberto Diletti, Antonio Colombo, et al

Watch time: 1h 49m 19s

Articles by Azeem Latib, Section Head of Interventional Cardiology

Transcatheter Heart Valves with Labelling for Aortic Regurgitation

Pier Pasquale Leone, Azeem Latib,

Published:

Citation: Interventional Cardiology 2025;20:e25.

Rediscovered and Unforgotten: Transcatheter Interventions for the Treatment of Severe Tricuspid Valve Regurgitation

Kusha Rahgozar, Sharon Bruoha, Edwin C Ho, et al

Published:

Citation: US Cardiology Review 2021;15:e22.

Transcatheter Mitral Valve Replacement: Current Evidence and Concepts

Ozan M Demir, Mhairi Bolland, Jonathan Curio, et al

Published:

Citation: Interventional Cardiology Review 2021;16:e07.

Rotational Atherectomy: A Contemporary Appraisal

Tanush Gupta, Michael Weinreich, Mark Greenberg, et al

Published:

Citation: Interventional Cardiology Review 2019;14(3):182–9.

Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment

Jonathan Curio, Ozan M Demir, Matteo Pagnesi, et al

Published:

Citation: Interventional Cardiology Review 2019;14(2):54–61.

Delayed Coronary Occlusion After Transcatheter Aortic Valve Implantation: Implications for New Transcatheter Heart Valve Design and Patient Management

Richard J Jabbour, Akihito Tanaka, Antonio Colombo, et al

Citation: Interventional Cardiology Review 2018;13(3):137–9.

Predilatation Prior to Transcatheter Aortic Valve Implantation: Is it Still a Prerequisite?

Matteo Pagnesi, Luca Baldetti, Paolo Del Sole, et al

Citation: Interventional Cardiology Review 2017;12(2):116–25.

Assessing the Risk of Leaflet Motion Abnormality Following Transcatheter Aortic Valve Implantation

Luca Testa, Azeem Latib,

Citation: Interventional Cardiology Review 2018;13(1):37–9.

How to Select the Most Appropriate Patient and Lesion to be Treated with a Coronary Bioresorbable Vascular Scaffold

Charis Costopoulos, Azeem Latib, Antonio Colombo, et al

Citation: Interventional Cardiology Review 2013;8(2):90-2